NewsBite

Ansell Limited

ASX Announcements

Dividend/Distribution - ANN

Dividend Record Date, Dividend Pay Date, Dividend Rate, Dividend Reinvestment Plan

  • Feb 10, 2025
  • 5 pages

Market Sensitive

Ansell HY FY25 Results Presentation

Half Yearly Report, Company Presentation

  • Feb 10, 2025
  • 33 pages

Market Sensitive

Ansell HY FY25 Results Announcement

Half Yearly Report, Periodic Reports - Other

  • Feb 10, 2025
  • 6 pages

Market Sensitive

Ansell HY FY25 Report & Accounts (Appendix 4D)

Half Yearly Report, Half Year Audit Review, Half Year Directors' Statement, Half Year Accounts, Half Year Directors' Report, Dividend Record Date, Dividend Pay Date, Dividend Rate

  • Feb 10, 2025
  • 29 pages

Becoming a substantial holder

Becoming a substantial holder

  • Jan 16, 2025
  • 10 pages

View all ANN announcements

This Month

JB Hi-Fi shares just keep going up.

What we learnt: Why market darlings JB Hi-Fi and Carsales got hammered

A couple of ASX darlings and a comeback story have grabbed our attention as earnings season ramps up. Profits are good but what does it mean for the RBA meeting?

  • James Thomson and Anthony Macdonald

Ansell to raise prices to offset US tariffs on China

Shares climb after the company lifts its interim dividend by 34.5 per cent and announces a 184 per cent surge in net profit to $US55 million.

  • Simon Evans

August 2024

Property giant Dexus has tweaked its dividend ratio so it has more capital available to move quickly if an opportunity presents itself.

Dexus’ big move and the other result that caught our eye

Dexus gives itself more wriggle room, Reliance Worldwide gets investor hearts racing, and Vicinity Centres goes further upmarket.

  • James Thomson and Anthony Macdonald

Ansell declares PPE glut over, sheds almost 10pc of its staff

Shares in the medical gloves group jumped as the chief executive confirmed 1330 jobs had been cut as it ramps up automation.

  • Simon Evans

April 2024

Ansell shows how to create new interest in an old story

Cheap stock never goes out of fashion. The key for a company is to issue it only occasionally, and make the most of when it does.

  • Anthony Macdonald
Advertisement

Ansell strikes ‘attractive’ $974m Kimberly-Clark deal

The maker of medical gloves is raising up to $465 million in capital to expand into scientific laboratories and safety eyewear with the Kimtech and KleenGuard brands.

  • Simon Evans

Terms out for Ansell’s $400m raising to acquire Kimberly-Clark unit

The company will split the acquisition financing into a $400 million placement, a $US377 bridge debt facility, and a $65 million share purchase plan.

  • Sarah Thompson, Kanika Sood and Emma Rapaport
Demand for Ansell’s medical suits and single-used examination gloves soared during the pandemic. That growth has now normalised, the company said.

Ansell prepares $400m equity raise for M&A; Goldies on ticket

Goldman Sachs started wall-crossing fund managers over the weekend ahead of the mooted cash call.  

  • Sarah Thompson, Kanika Sood and Emma Rapaport

February 2024

Ansell cuts almost 1300 jobs as profits keep sliding

The cut represents some 9 per cent of its global workforce. The company has also sliced its dividend payout after profits slumped by 70 per cent.

  • Simon Evans

January 2024

Mark Freeman says AFIC’s will always find opportunities to add to its high-quality portfolio in any given year.

Why Australia’s biggest and oldest LIC defied the Ozempic sell-off

Australian Foundation Investment Company boss Mark Freeman says buying CSL and Resmed amid last year’s Ozempic rout was part of a tried-and-true strategy. 

  • James Thomson

July 2023

Earnings season is forecast to deliver some low numbers, particularly on forward guidance.

Earnings season reality might be about to bite

Slowing economic growth has started bleeding into profit downgrades for 2024. Investors could be in for a volatile earnings season.

  • James Thomson
Some distributors are cutting back on orders for Ansell gloves.

Ansell shares plummet on glove glut, earnings warning

The maker of safety equipment flagged job cuts and major IT spending.

  • Liam Walsh
Ansell’s customers are re-thinking how much stock they really need.

Ansell much more than a case of a COVID hangover

The COVID-19 boom is well and truly over for Ansell, and what’s left is not a pretty picture. Expect some significant changes in the next year or two.

  • Updated
  • Anthony Macdonald

February 2023

Profit downgrades are reminding investors that conditions are tricky.

What we learnt: Profit downgrades end dash for trash

Having bid up some of last year’s most beaten-down stocks on hopes of a soft landing, investors are now being spooked by earnings downgrades. 

  • Updated
  • James Thomson
Ansell was a glamour stock in the pandemic where demand for single-use medical gloves soared.

Ansell’s painful post-COVID correction has six months to run

CEO Neil Salmon has been forced to slash his earnings forecast, triggering an 8 per cent sell-off in the shares.

  • Simon Evans
Advertisement

November 2022

Medical gloves maker Ansell hit on second front

Fallout from oversupply in medical gloves in the pandemic is still washing through, and now a slower economy hurts industrial orders.

  • Simon Evans

October 2022

Ansell faces class action over big profit downgrade

A heavy profit downgrade on January 31 that sent shares in the medical glove maker tumbling has Ansell in the sights of law firm Slater and Gordon.

  • Simon Evans

September 2022

Street Talk.

Rubbers hit the road in Lifestyles auction, PE finishes first

A US-based PE firm is in late-stage talks to acquire condom business LifeStyles Healthcare in a $US500 million-plus deal.

  • Yolanda Redrup, Sarah Thompson, Kanika Sood and Anthony Macdonald

August 2022

Golden glove days over for Ansell as pandemic fades

The group has two factories in Sri Lanka employing 5000 people and has paid extra wages to help them through an economic crisis.

  • Simon Evans

April 2022

Only last month, Ansell labelled the Russian business as one of its key growth areas.

Ansell to halt production at Russian factory in June

The $3b medical glove maker opened a new factory in western Russia in mid-2021, and is suspending production indefinitely in June.

  • Updated
  • Simon Evans

Original URL: https://www.afr.com/company/ann-3e